Elite Diagnostic Past Earnings Performance
Past criteria checks 1/6
Elite Diagnostic's earnings have been declining at an average annual rate of -21.4%, while the Healthcare industry saw earnings growing at 11.6% annually. Revenues have been growing at an average rate of 15.3% per year. Elite Diagnostic's return on equity is 1.4%, and it has net margins of 0.9%.
Key information
-21.4%
Earnings growth rate
-21.3%
EPS growth rate
Healthcare Industry Growth | -2.9% |
Revenue growth rate | 15.3% |
Return on equity | 1.4% |
Net Margin | 0.9% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Elite Diagnostic makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 767 | 7 | 317 | 0 |
31 Dec 23 | 764 | 0 | 297 | 0 |
30 Sep 23 | 764 | 2 | 285 | 0 |
30 Jun 23 | 755 | 13 | 277 | 0 |
31 Mar 23 | 740 | 18 | 273 | 0 |
31 Dec 22 | 699 | 40 | 255 | 0 |
30 Sep 22 | 669 | 55 | 233 | 0 |
30 Jun 22 | 624 | 49 | 211 | 0 |
31 Mar 22 | 591 | 40 | 208 | 0 |
31 Dec 21 | 559 | 16 | 197 | 0 |
30 Sep 21 | 538 | 12 | 186 | 0 |
30 Jun 21 | 507 | 2 | 175 | 0 |
31 Mar 21 | 458 | -13 | 157 | 0 |
31 Dec 20 | 440 | -20 | 158 | 0 |
30 Sep 20 | 432 | -18 | 150 | 0 |
30 Jun 20 | 440 | 9 | 144 | 0 |
31 Mar 20 | 463 | 48 | 142 | 0 |
31 Dec 19 | 459 | 66 | 135 | 0 |
30 Sep 19 | 437 | 67 | 135 | 0 |
30 Jun 19 | 405 | 52 | 133 | 0 |
31 Mar 19 | 367 | 49 | 122 | 0 |
31 Dec 18 | 338 | 40 | 113 | 0 |
30 Sep 18 | 313 | 36 | 105 | 0 |
30 Jun 18 | 298 | 45 | 89 | 0 |
31 Mar 18 | 304 | 30 | 90 | 0 |
31 Dec 17 | 291 | 42 | 76 | 0 |
30 Sep 17 | 276 | 49 | 65 | 0 |
30 Jun 17 | 263 | 44 | 63 | 0 |
30 Jun 16 | 194 | 29 | 61 | 0 |
Quality Earnings: ELITE has high quality earnings.
Growing Profit Margin: ELITE's current net profit margins (0.9%) are lower than last year (2.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ELITE's earnings have declined by 21.4% per year over the past 5 years.
Accelerating Growth: ELITE's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ELITE had negative earnings growth (-62.3%) over the past year, making it difficult to compare to the Healthcare industry average (29.3%).
Return on Equity
High ROE: ELITE's Return on Equity (1.4%) is considered low.